Protective effects of polydeoxyribonucleotides on cartilage degradation in experimental cultures
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The capacity of cartilage self‐regeneration is considered to be limited. Joint injuries often evolve in the development of chronic wounds on the cartilage surface. Such lesions are associated with articular cartilage degeneration and osteoarthritis. Re‐establishing a correct micro/macro‐environment into damaged joints could stop or prevent the degenerative processes. This study investigated the effect of polydeoxyribonucleotides (PDRNs) on cartilage degradation in vitro and on cartilage extracted cells. The activities of matrix metalloproteinases 2 and 9 were measured in PDRN‐treated cells and in controls at days 0 and 30 of culture. Human nasal cartilage explants were cultured, and the degree of proteoglycan degradation was assessed by measuring the amount of glycosaminoglycans released into the culture medium. The PDRN properties compared with controls were tested on cartilage tissues to evaluate deposition of extracellular matrix. Chondrocytes treated with PDRNs showed a physiological deposition of extracellular matrix (aggrecan and type II collagen: Western blot, IFA, fluorescence activated cell sorting, Alcian blue and safranin O staining). PDRNs were able to inhibit proteoglycan degradation in cartilage explants. The activities of matrix metalloproteinases 2 and 9 were reduced in all PDRN‐treated samples. Our results indicate that PDRNs are suitable for a long‐term cultivation of in vitro cartilage and have therapeutic effects on chondrocytes by protecting cartilage. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
González, A., Hall, M. N., Lin, S.-C., & Hardie, D. G. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.015 · Cited by 797
Osteoarthritis — an untreatable disease?
Wieland, H. A., Michaelis, M., Kirschbaum, B. J., & Rudolphi, K. A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1693 · Cited by 585
Altavilla, D., Bitto, A., Polito, F., Marini, H., Minutoli, L., Stefano, V., Irrera, N., Cattarini, G., & Squadrito, F. (2009) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152509789541909 · Cited by 107 · cited 1×
“Adenosine receptor stimulation can induce vascular endothelial growth factor expression in many types of cells, and this may be achieved by stimulating the A(2A) or A(2B) receptor or both.(4,5) Experimental models suggest that PDRNs may bind to the vascular endothelium, modulate platelet activity, promote fibrinolysis…”
Bitto, A., Polito, F., Irrera, N., D'Ascola, A., Avenoso, A., Nastasi, G., Campo, G. M., Micali, A., Bagnato, G., Minutoli, L., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30538 · Cited by 105
Rubegni, P., De Aloe, G., Mazzatenta, C., Cattarini, L., & Fimiani, M. (2001) · Current Medical Research and Opinion · doi:10.1185/0300799039117047 · Cited by 56 · cited 1×
“Thus, these molecules are used in therapy as a tissue repair stimulating agents in diseases characterized by a loss of substance, in hind limb ischemia and in burn injury.(13,14) Yet, PDRNs potently down-regulated heparanase, which is overexpressed in multiple myeloma plasma cells and is also correlated with progressi…”
Cited by
Pharmacological Activity and Clinical Use of PDRN
Squadrito, F., Bitto, A., Irrera, N., Pizzino, G., Pallio, G., Minutoli, L., & Altavilla, D. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00224 · Cited by 215
“PDRN has been also tested in primary chondrocytes (Gennero et al., 2013), where induced a physiological accumulation of the extracellular matrix with reduced proteoglycan degradation, reducing matrix metalloproteinases 2 and 9.”
Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing
Galeano, M., Pallio, G., Irrera, N., Mannino, F., Bitto, A., Altavilla, D., Vaccaro, M., Squadrito, G., Arcoraci, V., Colonna, M. R., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14111103 · Cited by 79
Colangelo, M. T., Galli, C., & Guizzardi, S. (2020) · Regenerative Medicine · doi:10.2217/rme-2019-0118 · Cited by 59
Veronesi, F., Dallari, D., Sabbioni, G., Carubbi, C., Martini, L., & Fini, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25663 · Cited by 58
Dallari, D., Sabbioni, G., Del Piccolo, N., Carubbi, C., Veronesi, F., Torricelli, P., & Fini, M. (2020) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000569 · Cited by 44
“A reduction in arthritis signs and proinflammatory cytokines production was also observed in mice affected by arthritis.(15,19) In addition, PNs lead to a reduction in knee OA symptoms, with an effect comparable with HA, but also with an earlier response compared with HA, in patients affected by OA.”
Background
Metadata
- Authors
- Gennero, L., Denysenko, T., Calisti, G. F., Vercelli, A., Vercelli, C. M., Amedeo, S., Mioletti, S., Parino, E., Montanaro, M., Melcarne, A., Juenemann, C., Vivo, E. D., Longo, A., Cavallo, G., & De Siena, R.
- Venue
- Cell Biochemistry and Function
- Publisher
- Wiley
- Published
- 2012-09-24
- Volume
- 31
- Issue
- 3
- Pages
- 214-227
- ISSN
- 0263-6484 (ISSN-L)
- 1099-0844
- OpenAlex
- W1487238564
- Cited by
- 47
- References
- 6
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.